Ethanol (EtOH) is one of the most frequently abused drugs with heavy health, economic, and societal burdens. Although moderate to low EtOH may have some neuroprotective effects, heavy EtOH consumption associated with high blood alcohol level (BAL) can be quite detrimental. The brain is particularly vulnerable to the damaging effects of high BAL, leading to neuronal loss, cognitive, and behavioral deficits. Although the exact causes of these detriments are not fully elucidated, it is believed that damage to the cholinergic system is at least partially responsible for the cognitive impairment. Thus, high BAL may result in selective apoptotic damage to the cholinergic neurons. Donepezil (DON), a centrally acting, reversible and noncompetitive acetylcholinesterase (AChE) inhibitor, approved for use in Alzheimer's disease (AD), may also attenuate EtOHinduced cognitive impairment. Cognitive effects of DON might be due to an anti-apoptotic activity as some AChE inhibitors have been shown to have this property. The aim of this study was to determine whether DON might protect against EtOH-induced toxicity and whether such protection might be apoptotically mediated. We exposed the human neuroblastoma-derived, SH-SY5Y cells to a relatively high concentration of EtOH (500 mM) for 24 h and evaluated the effects of two concentrations of DON (0.1 and 1.0 μM) on alcohol-induced toxicity and caspase-3, an apoptotic marker. We found a dose-dependent protection of DON against EtOH-induced toxicity as well as dose-dependent attenuation of EtOH-induced increases in caspase-3 levels. Thus, DON may inhibit apoptosis as well as alcohol-induced toxicity.
Introduction
Alcohol or ethanol (EtOH) is one of the most frequently abused drugs with heavy health, economic, and societal burdens (Goodwin et al. 1970; Tharp et al. 1974; Sacks et al. 2010; Antonelli et al. 2018 ). Moderate to low EtOH (two drinks for men and one for women) may reduce stress and increase feelings of well-being with some beneficial effects on cardiovascular and neuronal systems (Collins et al. 2008 (Collins et al. , 2010 Tizabi et al. 2018) . However, heavy EtOH consumption is quite detrimental to overall health (Churchill et al. 2008; Collins and Neafsey 2011; Krenz and Korthuis 2012; Su et al. 2017; Tizabi et al. 2018 ) and particularly to the central nervous system (Moonat et al. 2010; Collins and Neafsey 2011; Natarajan et al. 2015) . High blood EtOH levels lead to neuronal loss, brain shrinkage associated with reduced brain volume, enlarged ventricles, and increased cerebral spinal fluid levels (Pfefferbaum et al. 1992; Marrie et al. 2001; Moonat et al. 2010; Collins and Neafsey 2011; Natarajan et al. 2015) . These changes can result in behavioral deficits and cognitive dysfunction referred to as Balcoholic dementia^ (Goodwin et al. 1970; Tharp et al. 1974; Weissenborn and Duka 2000) . Although various neurotransmitter systems have been implicated, the cholinergic transmission may be a key player in cognitive dysfunctions induced by alcohol (Arendt et al. 1988; Gawel et al. 2016; Mulholland et al. 2018) . Indeed, Bcholinergic hypothesis^of dementia has been proposed. This hypothesis is based on observations that loss of basal forebrain cholinergic neurons and the consequent reduction of acetylcholine (ACh) significantly contribute to the cognitive impairments such as those associated with Alzheimer's disease (AD) or EtOH-related dementias (Bartus 2000; Sarter and Bruno 2004; Cutuli et al. 2013) . In AD models, studies have shown a marked neuroprotective effect of donepezil (DON), a centrally acting reversible and non-competitive AChE inhibitor (Yamamoto et al. 2010) . Indeed, DON is one of the very few drugs that is approved as a first-choice therapy for the treatment of mild to moderate AD (Small et al. 1997; Brodaty 1999; Giacobini 2000) .
In addition to causing a reduction in ACh, high EtOH damage may also involve neuronal death through apoptotic process (Guadagnoli et al. 2016; Heaton et al. 2003; Sun et al. 2017; Ieraci and Herrera 2018) . Apoptosis, a mechanism of programmed cell death, is essential for development and homeostasis, however, if over-activated, it can result in unintended neuronal death (Han et al. 2000; Kim and Zhao 2005; . Overexpression of caspases, proteases acting through specific signaling pathways, can lead to mitochondrial dysfunction and eventual death of the neuron (Green and Reed 1998; Thornberry and Lazebnik 1998) . Hence, caspases in general, and caspase-3 in particular, are measured as marker of apoptosis (Han et al. 2000; Kim and Zhao 2005; .
SH-SY5Y, human neuroblastoma-derived cells, are commonly used to investigate cellular/molecular mechanisms of drugs including EtOH-induced neurotoxicity and/or neurodegeneration (Ramlochansingh et al. 2011; Das and Tizabi 2009; Tizabi et al. 2012; Xicoy et al. 2017 ). Exposed to high EtOH (500 mM), cultured SHSY-5Y cells undergo apoptosis, which might be triggered via increased AChE activity (Sun et al. 2017) . Since DON is a potent AChE inhibitor and has been shown to protect against various toxic agents in SH-SY5Y cells (Das and Tizabi 2009; Sun et al. 2017 ), we undertook this study to evaluate possible protective effects of DON against EtOH-induced toxicity in these cells. Moreover, since caspase-3 has been implicated in EtOH-induced toxicity, the effects of DON on this protease were also evaluated. Our hypothesis was that DON will protect against EtOH-induced toxicity in SH-SY5Y cells and that at least part of this protection is mediated through caspase-3 reduction.
EtOH was obtained from EMD Chemicals Inc. (Gibbstown, NJ) and donepezil hydrochloride (donepezil HCl), (RS)-2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one was supplied by Ibaraki, Japan. Caspase-3 antibody was purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX). Western Blot and analytical reagents as well as MTT (3, (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) kit were purchased from Sigma Chemical Company (Sigma-Aldrich, St. Louis, MO). The SH-SY5Y human neuroblastoma cell lines (originally derived from a female patient) were purchased from American Type Culture Collection (ATCC, Manassas, VA); caspase-3 antibody from Santa Cruz (Dallas, Texas) and the secondary antibody from Thermo Scientific (Rockford, IL).
SH-SY5Y cells were cultured in a 1:1 mixture of Dulbecco's Modified Eagle Medium (DMEM) and Ham's F12 supplemented with 10% fetal bovine serum, penicillin/ streptomycin (100 IU/ml) at 37°C in 95% O 2 /5% CO 2 humidified incubator. The cells were trypsinized when confluent (> 90%) and plated in 96-well plates (approximately1.2 × 10 4 cells/well). Cells were allowed to adhere to bottom surface for 24 h. Then, fresh media containing various concentrations of drugs (EtOH, DON) were added to the carefully aspirated wells. In all cases, DON was added 2 h prior to alcohol. Control group consisted of cells that were maintained in media alone and without any drug treatment. All treatments were carried out for 24 h and the effects on cell viability was determined following the 24 h incubation. To determine the total caspase-3 levels, cells (approximately 1.9 × 10 5 ) were maintained in a 6-well culture plate to allow adequate protein harvesting. Here also, cells were pre-incubated with DON (0.1 and 1 μM), 2 h prior to the addition of EtOH. After 24 h incubation, the cells were harvested from the bottom of the wells for Western blot assay.
Determination of cell viability was performed by MTT colorimetric assay according to the manufacturer's protocol. Briefly, the yellow MTT tetrazolium salt (0.5 mg/ml) dissolved in DMEM and MTT (30 μL), was added to each well and incubated for 4 h at 37°C. The live cells cause a reduction of the yellow salt to insoluble purple formazan crystals. The wells were then aspirated, and 100 μL of 10% SDS (sodium dodecyl sulfate) was added to the wells to solubilize the crystals. The plates were then placed in an incubator at 37°C overnight and read spectrophotometrically at 570 nm with a background of 630 nm in a plate reader. Cell viability was determined by subtracting the test results from the background and is presented as a percentage of the control.
Following drug treatment, EtOH (500 mM), DON (0.1 and 1 μM) or their combination, cells were harvested and washed twice with cold PBS and subsequently lysed in × 1 SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) loading buffer (120 μL per well in 6-well plate). The lysed cells were heated to 95-100°C for 10 min followed by cooling on ice and centrifugation at 10,960×g for 1 min at 4°C. The protein concentration was determined by Peirce BCA method. Samples were electrophoresed through 10% polyacrylamide gels, transferred onto PVDF membranes, and immunoblotted with antibodies against total caspase-3 (1:250 dilution). Following incubation of the primary antibody, membranes were washed with tris-buffered saline (20 mM Tris/HCl, pH 7.5, and 150 mM NaCl) containing 0.1% Tween 20 and incubated in anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:10,000). Following secondary antibody incubation, membranes were washed with tris-buffered saline, incubated in SuperSignal West Dura Extended Duration Substrate (Thermo Scientific) followed by developing and image analysis.
Data is expressed as mean ± SEM. Statistical differences within and between treatment groups were determined by oneway ANOVA followed by post-hoc Newman-Keuls' multiple comparison test, where P < 0.05 was considered statistically significant. Data were analyzed using Graphpad Prism 3 (Graphpad Software, Inc., San Diego, CA).
Compared with the control group, cell viability was dosedependently reduced by EtOH treatment (Fig. 1) . Thus, the highest concentration of EtOH (500 mM) resulted in approximately 60% reduction (p < 0.01) in cell viability. Hence, this concentration of EtOH was used in all subsequent experiments. As depicted in Fig. 2 , pretreatment with DON resulted in reversal of EtOH-induced toxicity, where the lower concentration of DON (0.1 μM) resulted in 80% protection (P < 0.01) and the higher concentration of DON (1.0 μM) completely blocked the alcohol effect (P < 0.01). Neither concentration of DON had any effect of its own (Fig. 2) . Thus, there was a dose-dependent inhibition of EtOH-induced toxicity by DON where at 1.0 μM concentration, total block of EtOH toxicity was obtained. EtOH treatment resulted in 100% increase in caspase-3 levels, which was significantly reduced (to 25% P < 0.05) by the lower concentration of DON (0.1 μM) and completely blocked by the higher concentration of DON (1.0 μM, P < 0.01) (Fig. 3) . Hence, parallel to the inhibition of the toxic effects of EtOH, DON also dose-dependently inhibited EtOH-induced increases in caspase-3 levels. In this case also, total block of EtOH-induced increase in caspse-3 was obtained with 1.0 μM DON.
The results of this study indicate that donepezil, a cholinesterase inhibitor, may protect against alcohol-induced toxicity in neuroblastoma-derived SH-SY5Y cells. Moreover, the toxicity induced by the high alcohol concentration in these cells was associated with an increase in caspase-3, an apoptotic marker, which was dose-dependently blocked by donepezil. Thus, donepezil, which is an FDA-approved drug for AD, may be useful in countering alcohol toxicity as well.
Other in vitro studies have shown that exposure of the same cells to high alcohol concentration causes increases in AChE Fig. 2 Effects of donepezil (DON), 0.1 and 1 μM on EtOHinduced cell death in SH-SY5Y cells. DON was applied 2 h before EtOH (500 mM) and cells were incubated for 24 h. Values are mean ± SEM of 5 independent experiments. In every experiment, each sample was run in triplicate. **P < 0.01 compared to control, ## P < 0.01 compared to EtOH activity (Sun et al. 2017 ). Thus, it may be suggested that a decrease in ACh content due to an increase in the activity of the degrading enzyme may lead to eventual cell death (Sun et al. 2017) . It would be of significant interest to determine whether a similar phenomenon may occur in vivo, which would implicate ACh reduction as a major player in alcoholinduced cellular damage or death. Moreover, since the role of ACh in cognitive function is well-established, a mechanistic link between high alcohol and cognitive impairment may also be suggested. That donepezil may reverse these effects could indicate a novel intervention in alcohol-induced toxicity in general and its cognitive impairment, in particular. Clearly, in vivo follow-up studies are warranted. In this regard, beneficial effects of donepezil on behavioral deficits induced by cholinergic depletion and the concomitant hippocampal and neocortical neurodegeneration have been reported (Cutuli et al. 2013 ). In the same study, it was shown that the elevated caspse-3 levels induced by cholinergic lesions were also attenuated by donepezil (Cutuli et al. 2013) . More recently, the effectiveness of donepezil in reversing ethanol-induced cognitive impairments as well as morphological and epigenetic changes induced by intermittent ethanol exposure in adolescent rats have been reported (Gawel et al. 2016; Mulholland et al. 2018) .
Effects of Donepezil on EtOH-Induced Toxicity in SHSY-5Y Cells
It is also of relevance to note that caspases, a group of intracellular proteases, are responsible for the deliberate disassembly of cells into apoptotic bodies, resulting in a Bprogrammedĉ ell death (Thornberry and Lazebnik 1998) . Indeed, increases in caspase-3, a prominent protease, has been proposed as marker of early neurodegeneration including processes leading to AD (D'Amelio et al. 2012) . Conversely, downregulation of caspase-3 levels is indicative of inhibition of neuronal apoptosis and hence neuroprotection (Han et al. 2000; Kim and Zhao 2005; . Our findings are in concordance with studies that show EtOH can induce widespread apoptotic neurodegeneration as indicated via increased caspase activation (Sun et al. 2017; Ieraci and Herrera 2018) . Here also, the fact that donepezil could block alcohol-induced increases in caspase-3 levels suggests a novel mechanism in neuroprotective effect of donepezil.
Although a link between ACh reduction and apoptosis has been suggested (Cutuli et al. 2013; Sun et al. 2017) , it is likely that the actions of donepezil might not be solely due to its inhibition of AChE. This contention is based on a number of studies where direct interaction of donepezil with nicotinic receptors and neuroprotective effects of such interaction, at least against glutamate-induced toxicity, have been provided . Indeed, neuroprotective effects of nicotine against alcohol-induced toxicity and involvement of nicotinic receptors in such protection have been reported (Tizabi et al. 2005) . Moreover, activation of nicotinic receptors may lead to an anti-apoptotic effect via PI3K/Akt/Bcl2 signal transduction mechanism (Akaike et al. 2010) .
In addition, few reports suggest that some of the neuroprotective effects of donepezil might be mediated via σ1 receptors, activation of which can result in intracellular modulation of Ca2+ and mobilization of phospholipase C (PLC)/protein kinase C (PKC) transduction pathways. Activation of this signaling pathway can lead to neuroprotection by preventing oxidative stress and hence dysfunction of mitochondrial or Beta-Actin Fig. 3 Effects of ethanol (EtOH) 500 mM and donepezil (DON 0.1 and 1 μM) alone or in combination on caspase-3 levels in SH-SY5Y cells. DON was applied 2 h before EtOH and cells were incubated for 24 h. Immunoblots of beta-actin and total caspase-3 are included. Caspase-3 values were normalized per beta-actin protein.
Values are mean ± SEM of 4 independent experiments. In every experiment, each sample was run in duplicate. **P < 0.01 compared to control, # P < 0.05, ## P < 0.01 compared to EtOH endoplasmic reticulum ). Thus, donepezil may have variety of actions in addition to AChE inhibition. In summary, our findings indicate that high alcoholinduced cell death in SH-SY5Y cells is at least partially mediated via apoptosis and that donepezil, a cholinesterase inhibitor, can block this toxicity by inhibiting apoptosis. Thus, donepezil may be useful in countering alcohol-induced toxicity.
